Nedaplatin
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XA
CAS registry number (Chemical Abstracts Service)
0095734-82-0
Chemical Formula
C2-H8-N2-O3-Pt
Molecular Weight
303
Therapeutic Category
Antineoplastic agent
Chemical Names
cis-Diammine(glycolato-O¹,O²)platinum (WHO)
Platinum, diammine(hydroxyacetato(2-)-O¹, O²)-, (SP-4-3)-
Foreign Names
- Nedaplatinum (Latin)
- Nedaplatin (German)
- Nédaplatine (French)
- Nedaplatino (Spanish)
Generic Names
- Nedaplatin (OS: JAN)
- 254 S (IS)
- Latoplatin (IS)
- NSC 375101D (IS)
- S 254 (IS)
Brand Names
- Ao Xian Da
AosaiKang Pharmaceutical, China - Aqupla
Nichi-Iko Pharmaceutical, Japan - Jepaso
Simcere, China - Lu Bei
Qilu Pharmaceutical Group, China - Quan Bo
Jin Quan Bao Shan Bio Pharm, China
Glossary
| Term | Definition |
|---|---|
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
